# Comparison of QT Interval Readings Between Smartwatch Combined With Cardiologs Artificial Intelligence and 12-lead ECG

> **NCT05161065** · — · COMPLETED · sponsor: **Cardiologs Technologies** · enrollment: 50 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Cardiologs

## Key facts

- **NCT ID:** NCT05161065
- **Lead sponsor:** Cardiologs Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-12
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2023-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05161065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05161065, "Comparison of QT Interval Readings Between Smartwatch Combined With Cardiologs Artificial Intelligence and 12-lead ECG". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05161065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*